Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Significance of serum endothelial cell specific molecule-1 (Endocan) level in patients with erectile dysfunction: a pilot study

Abstract

This study aimed to measure the serum endocan level of patients with erectile dysfunction (ED) and to investigate the possible association between the Endothelial-specific molecule-1 (Endocan) level and ED. Twenty healthy and sixty-four male patients included in the study were divided into four groups: severe ED (19 patients), moderate ED (24 patients), mild ED (21 patients) and control group (20 healthy men). The erectile function of all the patients was evaluated using the International Index of Erectile Function-5 (IIEF-5) questionnaire. The body mass index (BMI) of each participant was determined, together with levels of fasting blood glucose, total testosterone, low- and high-density lipoprotein cholesterol, triglyceride and endocan in serum samples. No significant difference was found between the three ED groups and the control group in terms of the mean age, BMI and the levels of cholesterol and fasting blood glucose (P>0.05). The mean serum endocan level was found to 1.076±0.5, 0.674±0.40 and 0.671±0.3 ng ml−1 in the severe, moderate and mild ED groups, respectively. This indicated that the highest value was obtained from the severe ED group, and the difference between the severe ED group and the other groups was statistically significant. In the control group, the serum endocan level was 0.73±0.46 ng ml−1, which was significantly higher compared to the moderate and mild ED groups (P<0.05). The significant difference between the control and ED groups in terms of the serum endocan level can assist in the evaluation of endothelial pathologies in the etiology ED.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Pohjantahti-Maaroos H, Palomaki A, Hartikainen J . Erectile dysfunction, physical activity and metabolic syndrome: differences in markers of atherosclerosis. BMC Cardiovasc Disord 2011; 11: 36–44.

    CAS  Article  Google Scholar 

  2. 2

    Lewis RW, Fugl-Meyer KS, Corona G, Hayes RD, Laumann EO, Moreira ED Jr et al. Definitions/epidemiology/ risk factors for sexual dysfunction. J Sex Med 2010; 7: 1598–1607.

    Article  Google Scholar 

  3. 3

    Shaeer O, Shaeer K . The Global Online Sexuality Survey (GOSS). Erectile dysfunction among Arabic-speaking Internet users in the Middle East. J Sex Med 2011; 8: 2152–2160.

    Article  Google Scholar 

  4. 4

    Berrada S, Kadri N, Mechakra-Tahiri S, Nejjari C . Prevalence of erectile dysfunction and ts correlates: a population-based study in Morocco. Int J Impot Res 2003; 15: 1.

    Article  Google Scholar 

  5. 5

    Meldrum DR, Gambone JC, Morris MA, Meldrum DA, Esposito K, Ignarro LJ . The link between erectile and cardiovascular health: the canary in the coal mine. Am J Cardiol 2011; 15: 599–606.

    Article  Google Scholar 

  6. 6

    Vlachopoulos C, Rokkas K, Ioakeimidis N, Stefanadis C . Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links. Eur Urol 2007; 52: 1590–1600.

    CAS  Article  Google Scholar 

  7. 7

    Yao F, Huang Y, Zhang Y, Dong Y, Ma H, Deng C et al. Subclinical endothelial dysfunction and low-grade inflammation play roles in the development of erectile dysfunction in young men with low risk of coronary heart disease. Int J Androl 2012; 35: 653–659.

    CAS  Article  Google Scholar 

  8. 8

    Menon P, Kocher ON, Aird WC . Endothelial cell specific molecule-1 (ESM-1), a novel secreted proteoglycan stimulates vascular smooth muscle cell proliferation and migration. Circulation 2011; 124: A15455.

    Google Scholar 

  9. 9

    Lee W, Ku S-K, Kim S-W, Bae J-S . Endocan elicits severe vascular inflammatory responses in vitro and in vivo. J Cell Physiol 2014; 229: 620–630.

    CAS  Article  Google Scholar 

  10. 10

    Roudnicky F, Poyet C, Wild P, Krampitz S, Negrini F, Huggenberger R et al. Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. Cancer Res 2013; 73: 1097–1106.

    CAS  Article  Google Scholar 

  11. 11

    Chen LY, Liu X, Wang SL, Qin CY . Over-expression of the endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion. J Int Med Res 2010; 38: 498–510.

    CAS  Article  Google Scholar 

  12. 12

    Balta I, Balta S, Demirkol S, Mikhailidis DP, Celik T, Akhan M et al. Elevated serum levels of endocan in patients with Psoriasis vulgaris: correlations with cardiovascular risk and activity of disease. Br J Dermatol 2013; 169: 1066–1070.

    CAS  Article  Google Scholar 

  13. 13

    Balta I, Balta S, Koryurek OM, Demirkol S, Mikhailidis DP, Celik T et al. Serum endocan levels as a marker of disease activity in patients with Behcet disease. J Am Acad Dermatol 2014; 70: 291–296.

    CAS  Article  Google Scholar 

  14. 14

    Balta S, Mikhailidis DP, Demirkol S, Ozturk C, Kurtoglu E, Demir M et al. Endocan—a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study. Angiology 2014; 65: 773–777.

    Article  Google Scholar 

  15. 15

    Kose M, Emet S, Akpinar TS, Kocaaga M, Cakmak R, Akarsu M et al. Serum endocan level and the severity of coronary artery disease: a pilot study. Angiology 2014; 66: 727–731.

    Article  Google Scholar 

  16. 16

    Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A . The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830.

    CAS  Article  Google Scholar 

  17. 17

    Champion HC, Bivalacqua TJ, Hyman AL, Ignarro LJ, Hellstrom WJ, Kadowitz PJ . Gene transfer of endothelial nitric oxide syntase to the penis augments erectile responses in the aged rat. Proc Natl Acad Sci USA 1999; 96: 11648–11652.

    CAS  Article  Google Scholar 

  18. 18

    Ganz P, Vita JA . Testing endothelial vasomotor function: nitric oxide, a multipotent molecule. Circulation 2003; 108: 2049–2053.

    Article  Google Scholar 

  19. 19

    Behrendt D, Ganz P . Endothelial function: from vascular biology to clinical applications. Am J Cardiol 2002; 90: 40–48.

    Article  Google Scholar 

  20. 20

    Witztum JL, Steinberg D . Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785–1792.

    CAS  Article  Google Scholar 

  21. 21

    Drakopoulou M, Toutouzas K, Stefanadi E, Tsiamis E, Tousoulis D, Stefanadis C . Association of inflammatory markers with angiographic severity and extent of coronary artery disease. Atherosclerosis 2009; 206: 335–339.

    CAS  Article  Google Scholar 

  22. 22

    Morley JE, Korenman SG, Kaiser FE, Mooradian AD, Viosca SP . Relationship of penile brachial pressure index to myocardial infarction and cerebrovascular accidents in older men. Am J Med 1988; 84 (3 Pt 1): 445–448.

    CAS  Article  Google Scholar 

  23. 23

    Böhm M, Baumhäkel M, Teo K, Sleight P, Probstfield J, Gao P et al. ONTARGET/TRANSCEND Erectile Dysfunction Substudy Investigators Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials. Circulation 2010; 121: 1439–1446.

    Article  Google Scholar 

  24. 24

    Zakynthinos E, Pappa N . Inflammatory biomarkers in coronary artery disease. J Cardiol 2009; 53: 317–333.

    Article  Google Scholar 

  25. 25

    Bechard D, Scherpereel A, Hammad H, Gentina T, Tsicopoulos A, Aumercier M et al. Human endothelialcell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J Immunol 2001; 167: 3099–3106.

    CAS  Article  Google Scholar 

  26. 26

    Sarrazin S, Adam E, Lyon M, Depontieu F, Motte V, Landolfi C et al. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta 2006; 1765: 25–37.

    CAS  PubMed  Google Scholar 

  27. 27

    Yilmaz MI, Siriopol D, Saglam M, Kurt YG, Unal HU, Eyileten T et al. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease. Kidney Int 2014; 86: 1213–1220.

    CAS  Article  Google Scholar 

  28. 28

    Wang X-S, Yang W, Luo T, Wang J-M, Jing Y-Y . Serum endocan levels are correlated with the presence and severity of coronary artery disease in patients with hypertension. Genet Test Mol Biomark 2015; 19: 124–127.

    CAS  Article  Google Scholar 

  29. 29

    Lee G-K, Lee L-C, Chong E, Lee C-H, Teo S-G, Chia B-L et al. The longterm predictive value of the neutrophil-to-lymphocyte ratio in type 2 diabetic patients presenting with acute myocardial infarction. QJM 2012; 105: 1075–1082.

    CAS  Article  Google Scholar 

  30. 30

    Yao F, Huang Y, Zhang Y, Dong Y, Ma H, Deng C et al. Subclinical endothelial dysfunction and low-grade inflammation play roles in the development of erectile dysfunction in young men with low risk of coronary heart disease. Int J Androl 2012; 35: 653–659.

    CAS  Article  Google Scholar 

  31. 31

    Dong JY, Zhang YH . Qin LQ. Erectile dysfunction ana risk of cardiovascular disease meta-analysis of prospective cohort studies. J Am Coll Cardiol 2011; 58: 1378–1385.

    Article  Google Scholar 

  32. 32

    Inman BA, Sauver JL, Jacobson DJ, McGree ME, Nehra A, Lieber MM et al. A populationbased, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 2009; 84: 108–113.

    Article  Google Scholar 

  33. 33

    Karabakan M, Bozkurt A, Gunay M, Aktas BK, Hirik E, Aydın M et al. Association between serum fetuin-A level and erectile function. Andrologia 2015; 48: 787–792.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to M Karabakan.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Karabakan, M., Bozkurt, A., Akdemir, S. et al. Significance of serum endothelial cell specific molecule-1 (Endocan) level in patients with erectile dysfunction: a pilot study. Int J Impot Res 29, 175–178 (2017). https://doi.org/10.1038/ijir.2017.19

Download citation

Further reading

Search

Quick links